Development of classic dermatomyositis rash years after diagnosis of juvenile polymyositis.
Lieberman
Scott M
SM
Division of Rheumatology, The Children's Hospital of Philadelphia, PA, USA. liebermans@email.chop.edu
Sherry
David D
DD
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005076:Exanthema / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D006886:Hydroxychloroquine; D011241:Prednisone; D008775:Methylprednisolone